Arax Advisory Partners’s Indivior Pharmaceuticals INDV Stock Holding History
Bought
Maintained
Sold
Other funds holding INDV
OCM
TSC
Arax Advisory Partners's INDV Position: Q2 2026 in Review
Arax Advisory Partners opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 1,240 shares worth $50.9K. The stake represents ﹤0.01% of the portfolio and ranks #3251 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in INDV as recently as Q4 2025.
Arax Advisory Partners first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.
- Arax Advisory Partners held 1,240 shares of Indivior Pharmaceuticals worth $50.9K as of Q2 2026.
- Indivior Pharmaceuticals was a new Arax Advisory Partners position in Q2 2026.
- Indivior Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3251 holding.
- Arax Advisory Partners first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
- 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.